Ultra-slim Zafgen's candidate helps severely obese lose 1 Kg a week; plans Q3 PhII
This article was originally published in Scrip
Executive Summary
Two Zafgen Phase I studies show that its methionine aminopeptidase 2 (MetAP2) inhibitor, beloranib, helped severely obese people (body mass indexes on the order of the high 30s) lose about a 1 kilogram (2.2 pounds) a week showing during the one-month trial period.